There's An AI For That: the first AI cancer drug just worked

TL;DR: AI is transforming both ends of cancer simultaneously — from the first AI-designed drug to work in a human patient, REC-617, delivered in under 12 months, to screening that detects 30% more cancers, to uncovering hidden switches inside cells, to personalized cancer vaccines. But it has yet to rewrite the 90% drug trial failure rate. Humanity is still far from a "cure" — but AI is seizing cancer's deadliest weapon: the head start. # In 2025, the first AI-invented cancer drug worked This patient had ovarian cancer, and it had spread. She had been through four rounds of conventional treatment — none of which worked. For most of human history, the story would have ended here: the conversation with her doctor would no longer be about fighting, but about how much time she had left, about saying goodbye to the people she loved. But her doctor enrolled her in a trial for a drug called **REC-617**. That drug was born differently from any drug before it. ## How AI compressed a decade-long development cycle into one year Conventional cancer drug development works like this: scientists manually build thousands of possible drug candidates, then test them one by one. From project initiation to actually reaching a patient can take nearly a decade and cost upwards of a billion dollars. Recursion's AI took a completely different approach. It studied a target — a protein that cancer cells depend on to keep multiplying — and then designed candidate molecules on a computer, before anyone set foot in a lab to run an experiment. The team only had to build **136 candidate molecules** to find a winner, where normally it would take thousands. From idea to patient: **under 12 months**. ## The result: the tumor shrank by a third, and stayed put Once the drug entered her body, the tumor shrank by a third — and held steady month after month, clearing the six-month mark. In a cancer that no other drug had ever touched, another **29 patients** in the trial received the drug, and it proved safe at doses sufficient to work. But one response is not a cure, and to this day no AI-designed cancer drug has been approved anywhere on Earth. Her story matters for another reason: **AI designed a drug from scratch, and that drug worked inside a living human being.** The door everyone said would take decades to open is now wide open. # Why can't every patient use it? Because medicine spent over a century finally acknowledging a brutal truth: **there is no such thing as a disease called "cancer."** In 1971, U.S. President Richard Nixon signed the National Cancer Act and declared war on cancer, promising the same energy and resources that split the atom and put humans on the moon. Many believed a cure was less than ten years away. More than half a century later, after trillions — even tens of trillions — of dollars invested, cancer still kills more than 10 million people a year, and another 20 million are told they have it. ## "Cancer" is an umbrella term, not a disease What we call "cancer" encompasses hundreds of different diseases. **What breast cancer and leukemia have in common is less than what a flu and a bone fracture have in common.** The genes driving them are different, and so are the weaknesses that can kill them. Even within a single patient, "cancer" is not one disease. A tumor is a living colony of cells, constantly mutating and evolving. When a drug wipes out over 99% of those cells, the surviving 1% resistant cells survive, grow back, and gain immunity. **Doctors aren't fighting a disease — they're fighting evolution, with the fast-forward button pressed inside a human body.** This is exactly why REC-617 can't simply be handed to everyone: it opens only one particular lock, and only some cancers use that lock. Change the cancer, and the lock changes too. ## The deadliest thing is often not the disease, but the delay Take pancreatic cancer — one of the most lethal cancers on Earth. - **Found late**: only **3 out of 100** patients survive the first five years - **Found early**: that number jumps to around **45** Same organ, same disease — yet survivors multiply by **14×**, with the only difference being when it was discovered. This means **the most lethal part of cancer is not the disease itself, but the delay.** # AI screening: for cancer, the best treatment is often not treatment at all It sounds like heresy in a trillion-dollar industry, but for cancer, the best treatment isn't treatment. ## The Swedish experiment: AI reads films, finds 30% more cancers In January 2026, Swedish scientists released results from one of the largest experiments in the history of cancer screening. Over **100,000 women** walked into clinics for routine mammograms: - Half the films were read traditionally, by two human doctors - The other half were read with AI assistance The results shocked the medical world. **The AI side found 30% more cancers** — catching more fast-growing, aggressive tumors, the kind where every minute counts — while nearly halving the doctors' reading workload. Same patients, same doctors, same machines. The only new ingredient was AI, and cancers that would have slipped past were suddenly caught. ## Sybil: predicting the next six years, not reading today's cancer At MIT, researchers built a model called **Sybil**. Give it a lung scan, and it tells you your probability of developing lung cancer **within the next six years**. It isn't reading cancer that already exists in your body today — it's reading cancer that hasn't even formed yet: tissue patterns so subtle that even a radiologist wouldn't see them, no matter where to look. ## Galleri: one blood draw, screening dozens of cancers In the UK, scientists went further and scrapped the low-dose CT scan altogether. **142,000 people** simply provided a blood sample. A test called **Galleri**, an AI-powered assay, hunts for tiny DNA fragments left behind by shedding tumors. With each annual round of testing, fewer and fewer people are diagnosed at **stage four** — which is essentially the worst diagnosis in medicine. This is no longer science fiction. It's already version 1.0. # AI understanding biology: switches even scientists didn't know about Finding cancer is only half the equation. To truly defeat an enemy, you have to understand how it works. ## ARF1 and AVL9: a switch misread for decades In September 2026, Cornell scientists found something inside human cells — a switch that controls cancer, one that had been sitting in plain sight for decades, yet was missed right under the noses of every biologist on Earth. Deep in your cells is a protein called **ARF1**. Think of it as a logistics manager, deciding what gets shipped where. When this system breaks down, cancer often follows. For years, scientists wondered what turns this manager on and off. Finding the answer the traditional way would mean testing proteins one by one in the lab — enough to consume an entire scientist's career. The Cornell team took a shortcut: they handed the question to **AlphaFold**, Google's AI tool for predicting how proteins fit together, and let it scan for hidden patterns. The AI pointed to a protein called **AVL9** — which, according to textbooks, was supposed to be an "on" switch. The team's validation found the exact opposite: **it's actually an "off" switch**, a brake on the cell's logistics system, and nobody knew it existed. They then tested it on human lung cancer cells, and found that this hidden switch controls the cancer cells' ability to move — and movement is what makes cancer lethal: **tumors that stay put are easily removed**. The scientific community had catalogued this protein for years and completely misread it. AI flagged it in days. And Cornell was just one lab among many. ## More AI discoveries - **AI co-scientist**: Google's system was aimed at leukemia. After studying thousands of papers, it proposed several ready-made, already-approved drugs — that no doctor had ever thought to try. In actual testing, several of them killed leukemia cells in the lab at doses real patients could tolerate. - **Reading genetic mutations from images**: AI can now look at ordinary tissue slides under a microscope and detect genetic mutations that would normally require expensive DNA testing. The information was in the image all along — human eyes just couldn't see it. **For the first time in human history, we have a tool that can understand biology faster than biology can hide itself.** # Treatment: designing a drug for one person There are currently over **100 AI-designed drugs** in human trials, targeting everything from lung cancer to leukemia. One of them differs from anything in human history because it is **custom-built for every patient treated**. ## Merck and Moderna's personalized cancer vaccines Every tumor carries its own unique combination of mutations, like a fingerprint. A drug built for one fingerprint is often completely useless for another. So instead of making one drug for a million people, they're making **one drug for one person**. Here's how it works: 1. The doctor takes a small piece of the patient's tumor and reads its DNA 2. AI studies the mutations and selects a few targets the patient's immune system is most likely to recognize 3. A vaccine is built entirely from scratch, using only that patient's own material, teaching the body to hunt down that person's specific cancer In a melanoma trial, patients receiving it alongside standard therapy saw a **50% reduction in cancer recurrence risk**. In 2026, it passed the final stage of human trials, becoming the first personalized cancer therapy in medical history to do so. ## Isomorphic Labs: the biggest player in AI drug development has just entered The Google DeepMind team behind AlphaFold won a Nobel Prize for cracking the protein-folding problem. They then founded **Isomorphic Labs** with a single mission: design new drugs entirely with AI. Before the first drug even hit the market, pharmaceutical giants signed deals worth tens of billions of dollars with them. The first AI-manufactured drugs are expected to enter human trials within months. # The number that crushes every breakthrough: nine out of ten **90%** — that's the rate at which cancer drugs entering human trials ultimately fail. Not bad ideas from bad scientists. The best candidates on the planet, backed by tens of billions to trillions of dollars, still fail 90% of the time in testing. This number has shattered every wave of anti-cancer optimism over the past century — and AI has yet to rewrite it. To date, not a single AI-designed cancer drug has been approved anywhere in the world. ## The cautionary tale of IBM Watson A decade ago, IBM promised its famous Watson AI would revolutionize cancer care, and hospitals paid millions for it. Then internal documents leaked, revealing that some of Watson's recommended treatments were completely wrong — even unsafe — because it had been trained on fictional example cases, not real patients. Watson was quietly shelved, and oncologists learned to roll their eyes at "AI" and "cancer" appearing in the same sentence. ## What's different this time - **Watson never designed a drug.** It just repeated what humans fed it. Today's systems can uncover switches biologists missed and build molecules no one has ever seen. - The old system also had a fatal flaw: **every attempt took over a decade** — and failure meant losing a decade. AI compresses that decade into months. Recursion's drug went from idea to patient in under a year. - Even at a nine-out-of-ten failure rate, the drugs that survive now arrive years earlier. And every failure teaches the AI something — something no human team can absorb at this speed. **The failure rate hasn't dropped. The learning speed has gone exponential.** # Can AI cure cancer? The honest answer is far more complex than a simple "yes" or "no." ## What HIV teaches us In 1995, an HIV diagnosis meant death. Today, people with HIV can live full, normal lives, grow old, have children. **We have never cured HIV** — there's still no cure. We simply built the tools so well that the disease can no longer kill. ## Beating cancer may look like a system, not a bullet Cancer is a collection of hundreds of diseases. It will never be defeated by a single bullet — **it will be defeated by a system.** Imagine an annual checkup ten years from now: a single blood test screens for dozens of cancers at once; AI reads your scans and sees the first signs that cancer cells are beginning to form, six years out. If it finds something, it finds it so small that a simple procedure can end it. If it has already advanced beyond that, your tumor DNA is read and a drug is designed specifically for you. Throughout treatment, your blood is continuously monitored — and when any resistant cells try to make a comeback, they're caught long before any scanner ever sees them. None of the steps in that picture are science fiction. Today, every piece of it exists in some trial, some hospital, some lab. What's missing is the connective tissue: **scale, approval, and time.** And that gap is closing. Cancer blood tests are already on sale in the U.S. AI that reads mammograms is working in Swedish hospitals right now. Experts expect the remaining pieces to reach everyday patients within five years. # Conclusion: taking back the stolen time AI won't cure cancer with a single drug — certainly not this year. But AI is actively dismantling cancer's only real weapon: **the head start.** Every scan it reads a little earlier, every switch it finds, every drug it designs in months rather than years — each one chips away at that advantage. The woman in the REC-617 trial didn't get a miracle. She got a drug that bought her time. For 50 years, cancer has been stealing our time. And AI is how we steal it back. As the renowned futurist Ray Kurzweil once said: **"If you live long enough, technology will be there in time to save you."** For most of history, that was just a dream. In the next five years, just don't die. Source: There's An AI For That: the first AI cancer drug just worked — theimposingshadow (https://youtu.be/EtHlNpUaSUc?si=7f9hYibjdBcf7o2j)